Best Biopharma Outsourcing Companies in Shanghai, China
The 56 best Biopharma Outsourcing companies in Shanghai, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: ZGBiotech.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Shanghai
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AboutU Life Sciences Provider of recruitment services for life science industry | — | — | — | 2016 | Claudius Reinert Founder & Director | — | — | — |
| 2 | Acebright Manufacturer of APIs for pharmaceutical industry | — | — | 155 | 1996 | — | — | — | — |
| 3 | AURISCO Provider of contract based API products manufacturing and CRO services | — | — | 1,355 | 1998 | — | Windows ServerAnimate.cssMicrosoft ASP.NET+4 | — | 1 launch |
| 4 | Bidepharm CDMO focused on manufacturing API | — | — | 358 | 2007 | — | Cart FunctionalityTornadoServerTencent QQ+3 | — | — |
| 5 | Biochempartner Company offering APIs, intermediates, natural compounds and reagents for research and lab use | — | — | — | 2008 | Ke Xianxun Founder | — | — | — |
| 6 | Biomed Union Biotechnology company that specializes in the development and application of technologies in biomedical… | — | — | 40 | 2010 | — | — | — | — |
| 7 | BravoBio CDMO focused on manufacturing vaccines | — | — | 150 | 2011 | — | — | — | — |
| 8 | ChemExpress CDMO focused on manufacturing of APIs | — | — | 3,526 | 2006 | — | particles.jsAnimate.cssBootstrap+7 | — | — |
Top 12 Biopharma Outsourcing companies in Shanghai
#1
Seed · Shanghai, Shanghai · founded 2021$160Mraised▾
Biotechnology research company developing biological drugs. It is a biopharmaceutical research company that develops biological drugs including bispecific and multi specific antibodies, ADC, and new modalities.
- Jul 2025Seed$60M
- Dec 2024Seed$50M
- Nov 2021Angel$50M
#2
Series B · Shanghai, Shanghai$26Mraised▾
ChemLex is a knowledge-based company that focuses on closed-loop collaborative research and development through artificial intelligence chemical synthesis path planning and high-throughput. They offer comprehensive consulting services in the field of chemical legislation and plant protection products.
- Dec 2025Series B$45M
#3
Public · Shanghai, Shanghai · founded 2006 · 2271 employees$180Mraised▾
Viva is a multidisciplinary CRO with a focus on drug discovery and development. The company's services include Gene-to-protein and Gene-to-structure services, drug discovery with a focus on GPCR targets and antibody therapeutics discovery, fragment-based drug screening, medicinal chemistry, translational and in vivo pharmacology, in vitro pharmacology, DMPK and protein analysis, including crystallography services.
- Jun 2023Post IPO—
- Jan 2020Post IPO$180M
- 2017Series A—
#4
Series C · Shanghai, Shanghai · founded 2017 · 600 employees$239.7Mraised▾
CDMO focused on drug development, analytical, formulation, and quality testing services
- Aug 2022Series C$14.7M
- Jan 2022Series C$100M
- Mar 2021Series B$70M
- Mar 2020Series A$51M
#5
Series D · Shanghai, Shanghai · founded 2014 · 70 employees$201.9Mraised▾
Provider of cell-therapy focused research and development services
- Mar 2021Series D—
- Dec 2018Series C$135.7M
- Nov 2018Series C$39.6M
- 2016Series B$26.6M
#6
Series B · Shanghai, Shanghai · founded 2019 · 50 employees$132Mraised▾
Limited information available
- Mar 2021Series B$100M
- Jul 2020Series A$32M
#7
Series C · Shanghai, Shanghai · founded 2007 · 200 employees$29.3Mraised▾
Shanghai Bocimed Pharmaceutical develops and manufactures APIs and intermediates. The products are of various therapeutic categories including cardiovascular, respiratory, mental disorders, analgesia, anesthesia, anti-infection, antitumor, endocrine, metabolic, nervous system, etc. They also provide services such as project management, clinical monitoring, medical writing, data management and statistical analysis, project inspection, etc.
- Feb 2023Series C$14.6M
- Sep 2020Series B$14.7M
- Feb 2019Series A—
#8
Public · Shanghai, Shanghai · founded 2000 · 1681 employees$40Mraised▾
WuXi AppTec is a provider of a suite of CRO and CDMO services for small molecules, biologics, and medical devices. It offers a suite of services for the research, development, and manufacturing of both small molecules and biologics and also caters to medical device development and has operations all over the globe. They provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody, and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services. In 2022, the company recorded annual revenues of $5.84B and a net profit of $1.31B.
- Apr 2021Post IPO$15.9M
- Aug 2020Post IPO$950.6M
- Mar 2016Conventional Debt$1.5B
- Jul 2008Series C—
#9
Series A · Shanghai, Shanghai · founded 2020$14.7Mraised▾
Provider of protein reagents, kits, and related products for biopharmaceutical applications. It offers a range of products including protein raw materials, quality control testing kits, and diagnostic reagents. These products support new drug research and development, vaccine development, cell therapy, and diagnostic applications. The company focuses on developing high-quality protein materials and diagnostic testing products.
- Jan 2023Series A$14.7M
#10
Series A · Shanghai, Shanghai · founded 2020 · 100 employees$15.4Mraised▾
Provider of clinical trial services to biopharma sector
- Oct 2022Series A—
- Jul 2021Series A$15.4M
- Jan 2021Seed—
#11
Acquired · Shanghai, Shanghai · founded 1995 · 66 employees$62Mraised▾
Full-service CRO based out of China and East Asia. They offer consulting, project management, regulatory affairs, site management, clinical trial design, clinical operations, and central laboratory services.
- Oct 2019Series D$62M
#12
Series A · Shanghai, Shanghai · founded 2007 · 4 employees$4.4Mraised▾
Shanghai AQ BioPharma specializes in the research, development and manufacturing of fluorine-based compounds. The company claims to offer a product portfolio which includes 3000+ products, which as per company claims, are protected by 18+ patents. The company has expertise in the development of fluorinated drug intermediates, and rare, novel and drug-like N-based heterocyclic compounds such as piperidines, piperazines, pyrrolidines, azaindole, adamantane, azaspiro- and aza-fused heterocycles. The company's research projects were supported by SME Technology Innovation Fund. The company claims that their clientele includes 500 international customers, which include global pharmaceutical companies, research institutes and universities. The company also capabilities to offer medicinal chemistry services.
- Sep 2020Series A$4.4M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Shanghai is moving
A read on the academic research around Biotechnology in Shanghai — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 372 papers.
Shanghai Jiao Tong University and peers lead optimistic (mean stance 0.54) research into nanoplatforms for cancer theranostics and CRISPR, with breakthroughs dominating and concern papers minimal.
- Shanghai Jiao Tong University107
- Shanghai Ocean University33
- Shanghai University of Traditional Chinese Medicine21
- Shanghai Academy of Agricultural Sciences19
- Shanghai Institute of Materia Medica16
- Gene1→18
- In vitro1→3
- Enzyme1→3
- Fluorescence2→3
- Apoptosis1→6
- Gene1→6
- In vivo2→6
- Flow cytometry1→3
- Function (biology)1→3
- Agriculture1→3
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.